Screening sensitivity and sojourn time from breast cancer early detection clinical trials: Mammograms and physical examinations

Journal of Clinical Oncology

Volumn 19, Issue 15, 2001, Pages 3490-3499

  Shen, Y ^a   Zelen, M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

EID: 0035425426     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.15.3490     Document Type: Article

References (43)

1. On the theory of screening for chronic diseases
2. The theory of periodic screening: I. Lead time and proportion detected
3. The theory of periodic screening: II. Doubly bounded recurrence times and mean lead time and detection probability estimation
4. Screening for the early detection of cancer: III. Estimation of disease natural history
5. Estimation of the duration of a preclinical disease state using screening data
6. Simplified models of screening for chronic disease: Estimation procedures from mass screening programmes
7. Estimating asymptomatic duration in cancer: The AIDS connection
8. Parametric estimation procedures for screening programmes: Stable and nonstable disease models for multimodality case finding
9. Evidence on screening for breast cancer from a randomized trial
10. Five-year experience with single-view mammography randomized controlled screening in Sweden
11. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial
12. Update of the Swedish two-county program of mammographic screening for breast cancer
13. What can we learn from interval carcinomas?
14. Mammographic screening and mortality from breast cancer: The Malmö mammographic screening trial
15. Randomized mammographic screening for breast cancer in Stockholm
16. Analysis of interval breast carcinomas in a randomized screening trial in Stockholm
17. The Stockholm breast cancer screening trial: 5-year results and stage at discovery
18. The Gothenburg breast screening trial: First results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization
19. First results on mortality reduction in the UK trial of early detection of breast cancer. UK Trial of Early Detection of Breast Cancer Group
20. Edinburgh trial of screening for breast cancer: Mortality at seven years
21. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years
22. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years
23. Update of the Swedish two-county program of mammographic screening for breast cancer
24. Modeling the analysis of breast cancer screening programmes: Sensitivity, lead time, and predictive value in the Florence District programme (1975-1986)
25. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase
26. Efficacy of breast cancer screening by age
27. A Markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening
28. The natural history of breast carcinoma
29. A mover-stayer mixture of Markov chain models for the assessment of dedifferentiation and tumour progression in breast cancer
30. Benefits and risks of screening mammography for women in their forties: A statistical appraisal
31. Deficiencies in the analysis of breast cancer screening data
32. Is screening for breast cancer with mammography justifiable?
33. Assessment of nationwide cancer-screening programmes
34. Screening mammography re-evaluated
35. Screening mammography re-evaluated
36. Screening mammography re-evaluated
37. Screening mammography re-evaluated
38. Screening mammography re-evaluated
39. Planning clinical trials to evaluate early detection programmes
40. Overdiagnosis of medullary carcinoma: A mammographic-pathologic correlative study
41. Evaluation of overdiagnosis of breast cancer in screening with mammography
42. Screening theory and study design: The basics